Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Transmission of hepatitis C virus infection through tattooing and piercing: a critical review.
Tohme RA, Holmberg SD.
Clin Infect Dis. 2012 Apr;54(8):1167-78. Epub 2012 Jan 30.
Related citations
A multistate outbreak of hepatitis a associated with semidried tomatoes in Australia, 2009.
Donnan EJ, Fielding JE, Gregory JE, Lalor K, Rowe S, Goldsmith P, Antoniou M, Fullerton KE, Knope K, Copland JG, Bowden DS, Tracy SL, Hogg GG, Tan A, Adamopoulos J, Gaston J, Vally H.
Clin Infect Dis. 2012 Mar;54(6):775-81. Epub 2012 Jan 11.
Hepatitis a epidemiology goes global.
Holmberg SD.
Clin Infect Dis. 2012 Mar;54(6):782-3. Epub 2012 Jan 11. No abstract available.
Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons.
Thomas DL, Bartlett JG, Peters MG, Sherman KE, Sulkowski MS, Pham PA.
Clin Infect Dis. 2012 Apr;54(7):979-83. Epub 2012 Feb 4.
Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
Sheng WH, Hung CC, Chang SY, Liu CJ, Chen MY, Hsieh SM, Kao JH, Chen PJ, Chang SC.
Clin Infect Dis. 2012 Feb 15;54(4):548-55. Epub 2011 Dec 7.
Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individuals.
Vogel M, Page E, Boesecke C, Reiberger T, Schwarze-Zander C, Mauss S, Baumgarten A, Wasmuth JC, Nelson M, Rockstroh JK; European AIDS Treatment Network (NEAT) Study Group.
Clin Infect Dis. 2012 Feb 15;54(4):556-9. Epub 2011 Dec 7.
Boceprevir and telaprevir in the management of hepatitis C virus-infected patients.
Butt AA, Kanwal F.
Clin Infect Dis. 2012 Jan 1;54(1):96-104. Epub 2011 Dec 7. Review.
Prevalence of and risk factors for hepatitis B viremia after spontaneous hepatitis B surface antigen seroclearance in hepatitis B carriers.
Chu CM, Liaw YF.
Clin Infect Dis. 2012 Jan 1;54(1):88-90. Epub 2011 Nov 3.
Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis C.
Rallón NI, Morello J, Labarga P, Benito JM, Rodríguez-Nóvoa S, Vispo E, Barreiro P, Castro MÁ, Aguirrebengoa K, Pineda JA, Miralles P, Tellez MJ, Portu J, Miralles C, Ocampo A, Soriano V; Peginterferon Ribavirin Coinfection Team.
Clin Infect Dis. 2011 Dec;53(12):1291-5. Epub 2011 Oct 25.
Importance of minimal residual viremia for relapse prediction in patients with chronic hepatitis C genotype 1 infection.
Wiegand J, Neumann K, Böhm S, Weich V, Teuber G, Klinker H, Möller B, Rasenack J, Hinrichsen H, Gerlach T, Spengler U, Buggisch P, Sarrazin C, Berg T.
Clin Infect Dis. 2011 Dec;53(11):1111-4. Epub 2011 Oct 21.
Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.
Smith BD, Teshale E, Jewett A, Weinbaum CM, Neaigus A, Hagan H, Jenness SM, Melville SK, Burt R, Thiede H, Al-Tayyib A, Pannala PR, Miles IW, Oster AM, Smith A, Finlayson T, Bowles KE, Dinenno EA.
Clin Infect Dis. 2011 Oct;53(8):780-6.
Acute hepatitis associated with autochthonous hepatitis E virus infection--San Antonio, Texas, 2009.
Tohme RA, Drobeniuc J, Sanchez R, Heseltine G, Alsip B, Kamili S, Hu DJ, Guerra F, Teshale EH.
Clin Infect Dis. 2011 Oct;53(8):793-6. Epub 2011 Sep 6.
Prolonged survival of hepatitis C virus in the anesthetic propofol.
Steinmann E, Ciesek S, Friesland M, Erichsen TJ, Pietschmann T.
Clin Infect Dis. 2011 Nov;53(9):963-4. Epub 2011 Aug 31. No abstract available.
Genotypic distribution of hepatitis B virus (HBV) among acute cases of HBV infection, selected United States counties, 1999-2005.
Teshale EH, Ramachandran S, Xia GL, Roberts H, Groeger J, Barry V, Hu DJ, Holmberg SD, Holtzman D, Ward JW, Teo CG, Khudyakov Y.
Clin Infect Dis. 2011 Oct;53(8):751-6. Epub 2011 Aug 22.
Hepatitis B and the need for a booster dose.
Leuridan E, Van Damme P.
Clin Infect Dis. 2011 Jul 1;53(1):68-75.
Error occurred: cannot get document summary
All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population.
El-Kamary SS, Jhaveri R, Shardell MD.
Clin Infect Dis. 2011 Jul 15;53(2):150-7. Epub 2011 Jun 10.
Economic analysis of hepatitis B screening and treatment.
Lo Re V 3rd.
Clin Infect Dis. 2011 Jun;52(11):1307-9. Epub 2011 May 2. No abstract available.
The cost-effectiveness of screening for chronic hepatitis B infection in the United States.
Eckman MH, Kaiser TE, Sherman KE.
Clin Infect Dis. 2011 Jun;52(11):1294-306. Epub 2011 May 2.
Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.
Mendeni M, Focà E, Gotti D, Ladisa N, Angarano G, Albini L, Castelnuovo F, Carosi G, Quiros-Roldan E, Torti C.
Clin Infect Dis. 2011 May;52(9):1164-73.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on